Fulcrum Therapeutics Inc (FULC) Stock: A Year of Highs and Lows

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Fulcrum Therapeutics Inc’s current trading price is -34.85% away from its 52-week high, while its distance from the 52-week low is 185.10%. The stock’s price range during this period has varied between $2.32 and $10.13. The company, active in the Healthcare sector, saw a trading volume of around 1.17 million for the day, considerably higher average daily volume of 0.51 million observed over the last three months.

Fulcrum Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $10.13 on 08/15/24, and the lowest price during the same period was recorded at $2.32 on 04/07/25.

How Financial Performance Impacts Market Capitalization

Fulcrum Therapeutics Inc (FULC) has experienced a quarterly rise of 77.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 356.26M and boasts a workforce of 45 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.83, with a change in price of +2.37. Similarly, Fulcrum Therapeutics Inc recorded 583,951 in trading volume during the last 100 days, posting a change of +56.03%.

How FULC’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for FULC stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.

FULC Stock Stochastic Average

As of today, the raw stochastic average of Fulcrum Therapeutics Inc over the last 50 days is at 99.42%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 99.30%. Further, the company’s Stochastic %K and %D values for the last 20 days were 90.72% and 87.23%, respectively.

FULC Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant gain of 40.43% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 81.32%. Over the past 30 days, the price of FULC has fallen by 117.11%. And in the last five days, it has surged by 22.00%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.